FSD Pharma to Attend 41st Annual J.P. Morgan Healthcare Conference 2023
Stock Information for FSD Pharma Inc.
Please wait while we load your information from QuoteMedia.
More Recent News About FSD Pharma Inc.
FSD Pharma Announces Its Australian Entity Receives Approval to Proceed With Phase 1 Clinical Trial of Lucid-201, a Candidate for the Potential Treatment of Major Depressive Disorder
FSD Pharma (Symbol: HUGE) Renews Shareholder Intelligence Services to Investigate Possible Naked Short Selling and Appeals to The Regulators and Oversight Bodies to Look Into The Short Selling Activity Of Its Stock
InvestmentPitch Media Video Discusses FSD Pharma's Addition of Kevin Harrington, Author, "Shark Tank" Original, and Infomercial Pioneer to its Advisory Board
FSD Pharma Presenting Two Scientific Posters on Preclinical Toxicology and Efficacy Data of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2023 Forum
FSD Pharma Launches A New Research and Development Program Targeting Unmet Medical Needs for Alcohol Misuse